Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-04-27FDA Approved: DESVENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals Limited's supplemental application for desvenlafaxine succinate, a generic version of desvenlafaxin…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial [Phase 2]
A Phase 2 pilot trial evaluated a medication for young adults with comorbid major depressive disorder and alcohol use disorder; the study is…
-
CLINICAL_TRIALS research · 2017-04-27Clinical Trial Update: Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress [NA]
Clinical trial update from University of Rochester on managing sleep symptoms and mechanisms of traumatic stress in PTSD/depression; the stu…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Depression Outpatient Cardiology Screening Study [NA]
Completed clinical trial evaluating depression screening in outpatients with coronary heart disease; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Stimulant Enhancement of Well-Being Therapy for Depression [NA]
A terminated clinical trial evaluating stimulant augmentation of well-being therapy for Major Depressive Disorder has posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED) [Phase 3]
Phase 3 trial of MK0869 for major depressive disorder has completed.
-
CLINICAL_TRIALS research · 2017-04-26Clinical Trial Update: A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression [NA]
An update on a clinical evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for treatment-resistant depression, sponsored by Ab…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Antidepressant Therapy in Treating Bipolar Type II Major Depression [Phase 4]
Phase 4 clinical trial evaluating antidepressant therapy for bipolar II disorder with major depressive episodes has completed, with results …
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Imaging Biomarkers for TMS Treatment of Depression [NA]
A completed clinical trial investigating imaging biomarkers associated with transcranial magnetic stimulation (TMS) treatment for depression…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Ginger.io Behavioral Health Study [NA]
The Ginger.io Behavioral Health Study (NCT02491307), sponsored by Community Health Center, Inc., has been terminated and involved anxiety, d…
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study [NA]
The trial comparing supplemental Transcranial Magnetic Stimulation (TMS) to standard medication monotherapy for major depressive disorder ha…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Vilazodone for the Treatment of Posttraumatic Stress Disorder [Phase 4]
Phase 4 clinical trial update on vilazodone for posttraumatic stress disorder; the study is reported as completed.
-
CLINICAL_TRIALS research · 2017-04-21Clinical Trial Update: PET Imaging of mGLuR5 With Drug Challenge [NA]
This clinical trial update reports a completed PET imaging study of mGluR5 with a drug challenge in major depressive disorder and post-traum…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial [NA]
A completed 12-week trial evaluating the efficacy and safety of duloxetine in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder [NA]
Clinical trial results comparing ketamine to placebo for treatment-resistant major depressive disorder have been posted. The study is comple…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders [Phase 4]
This clinical trial update reports on a Phase 4 study of escitalopram in adolescents with major depressive disorder or anxiety disorders, wi…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects [Phase 2]
Phase 2 clinical trial evaluating the efficacy of mirtazapine for depressive symptoms in individuals with cocaine dependence; results have b…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Ketamine Infusion for Treatment-resistant Major Depressive Disorder [NA]
This is an update on a completed clinical trial (NCT01582945) from Massachusetts General Hospital evaluating ketamine infusion for treatment…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder
Completed clinical trial investigating methods to measure adherence to prescribed medications for major depressive disorder and ADHD.
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Motivational Interviews for Depression in Primary Care [NA]
Completed clinical trial evaluating motivational interviews for depression in primary care; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring [EARLY_Phase 1]
A Phase 1 trial evaluated transcranial magnetic stimulation for major depressive disorder with EEG and near-infrared spectroscopy monitoring…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT) [Phase 2]
A Phase 2 trial investigated intravenous scopolamine as an adjunct to electroconvulsive therapy for depression. The study was terminated and…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Psychological, Sexually and Social Consequences of Osteoarthritis Treatment With THA or TKA and Joint Preserving Surgery
This clinical trial update reports on the psychological, sexual, and social outcomes following osteoarthritis treatment with total hip arthr…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Natural Supplements for Unipolar Depression [Phase 4]
A Phase 4 clinical trial evaluating natural supplements for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059) [Phase 3]
Phase 3 trial evaluating MK0869 for major depressive disorder has completed.